Deal title |
Principal company |
Partner company |
Total paid (US$M) |
Technologies |
Date |
October | |||||
Finch Therapeutics merges with Crestovo |
Crestovo LLC |
Finch Therapeutics |
Unknown |
Small-molecule therapeutic |
10/23/17 |
Ligand Pharmaceuticals acquires Crystal Bioscience |
Crystal Bioscience Inc. |
Ligand Pharmaceuticals Inc. |
$25.00 |
Antibody |
10/6/17 |
Mitsubishi Tanabe Pharma's SPC reverse merges with Neuroderm |
Neuroderm Ltd |
Mitsubishi Tanabe Pharma Corp. |
$1,100.00 |
Small-molecule therapeutic |
10/18/17 |
GL Capital Management acquires Sciclone |
Sciclone Pharmaceuticals Inc. |
GL Capital Management Ltd. |
$605.00 |
Small-molecule therapeutic |
10/13/17 |
November | |||||
Alcobra and Arcturus Therapeutics merge to form a combined company in an all-stock transaction |
Arcturus Therapeutics Ltd. |
Alcobra Ltd. |
Unknown |
Oligonucleotide antisense |
11/15/17 |
Melinta reverse merges with Cempra |
Cempra Inc. |
Melinta Therapeutics Inc. |
Unknown |
Small-molecule therapeutic; antibiotic |
11/3/17 |
Ultragenyx acquires Dimension Therapeutics |
Dimension Therapeutics Inc. |
Ultragenyx Pharmaceutical Inc. |
$151.00 |
Small-molecule therapeutic |
11/7/17 |
Oncoresponse acquires Paganini Biopharma |
Paganini Biopharma Inc. |
Oncoresponse Inc. |
Unknown |
Monoclonal antibody human; biological therapeutic; immuno-oncology; |
11/7/17 |
Cerecor acquires Zylera Pharma |
Zylera Pharmaceuticals LLC |
Cerecor Inc. |
$4.00 |
Small-molecule therapeutic |
11/17/17 |
December | |||||
Mallinckrodt acquires Ocera Therapeutics |
Ocera Therapeutics Inc. |
Mallinckrodt plc |
$42.00 |
Small-molecule therapeutic |
12/11/17 |
|
Notes Source: Cortellis Deals Intelligence | |||||